Physician profile
Heather Parker
NPI 1518018423
$2,087.38
in general payments reported to CMS, 2019-2025
11 companies · $663 in 2025
The $663 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $177 · 2023: $579 · 2024: $668 · 2025: $663.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,910.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,909.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,149.85 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Acera Surgical, INC. | $223.89 | 2024 | Restrata Wound Matrix |
| Solventum Corporation | $215.31 | 2024-2025 | V.A.C.Ulta, V.A.C. Granufoam, Activ.A.C. |
| Next Science LLC | $157.22 | 2025 | Blastx, Xperience |
| Davol INC. | $96.27 | 2024 | Arista Ah Flexitip |
| Kerecis Limited | $86.67 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Abiomed | $56.13 | 2024 | Impella |
| Convatec INC. | $28.46 | 2025 | |
| Revance Therapeutics, INC. | $25.37 | 2024 | Daxxify |
| Smith+Nephew, INC. | $25.29 | 2023 | Grafix Pl, Oasis, Stravix Pl |
| Galderma Laboratories, L.P. | $22.92 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Parker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.